I-ONE (PEMF): An Innovative Approach to Non-Invasive Orthopaedic HealingDiscover the cutting-edge I-ONE Pulsed Electromagnetic Field (PEMF) therapy device by Igea Medical, designed for effective pain management and joint healing in orthopaedic care. This user-friendly device targets musculoskeletal conditions such as post-surgical pain, sports injuries, and inflammatory issues by emitting low-frequency electromagnetic pulses that stimulate cellular repair and enhance…Discover the cutting-edge I-ONE Pulsed Electromagnetic Field (PEMF) therapy device by Igea Medical, designed for effective pain management and joint healing in orthopaedic care. This user-friendly device targets musculoskeletal conditions such as post-surgical pain, sports injuries, and inflammatory issues by emitting low-frequency electromagnetic pulses that stimulate cellular repair and enhance natural healing. Clinically effective for athletes and patients recovering from surgery, the I-ONE device reduces inflammation, accelerates recovery times, and improves mobility without the need for drugs or invasive procedures. With proven efficacy backed by clinical studies, the compact and portable I-ONE device is ideal for clinical and home use, revolutionizing the approach to musculoskeletal health by providing a safe, consistent, and innovative solution for pain management.
Microfracture Doom to FailMicrofracture surgery, commonly used to repair damaged knee cartilage, is often questioned for its long-term success. This article explores why microfracture surgery fails and discusses alternatives for cartilage repair such as autologous chondrocyte implantation (ACI), mosaicplasty, and mesenchymal stromal cells. The limitations of microfracture surgery include the body's struggle to…Microfracture surgery, commonly used to repair damaged knee cartilage, is often questioned for its long-term success. This article explores why microfracture surgery fails and discusses alternatives for cartilage repair such as autologous chondrocyte implantation (ACI), mosaicplasty, and mesenchymal stromal cells. The limitations of microfracture surgery include the body's struggle to balance between durable healing and repeated injury, resulting in the breakdown of repair tissue over time. Additionally, the articular cartilage's limited capacity to heal leads to pain recurrence and post-traumatic arthritis. Long-term outcomes vary, with a risk of osteoarthritis progression in older patients. Alternatives like ACI and mosaicplasty show promise, although ACI has a high reoperation rate. Mesenchymal stromal cells are also being considered for enhancing cartilage repair.